跳至主要内容
临床试验/ISRCTN69963079
ISRCTN69963079已完成未知

A trial to prevent disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis (JIA)

Interdisciplinary Center For Clinical Research Muenster (Interdisziplinäres Zentrum für Klinische Forschung) (Germany)0 个研究点目标入组 114 人开始时间: 2013年3月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
114

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35260388/ (added 14/03/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients with polyarticular course of any JIA subcategory will be included at first confirmation of remission on medication, i.e. after clinically documented inactive disease for 6 months. At the time remission is documented, patients may be only on non-steroidal anti-inflammatory drugs (NSAIDs) plus DMARDs and/or biologics at a stable dose. Steroids must have beenwithdrawn at least 1 month before remission is documented. Intraarticular joint injections should not have been performed 6 months before remission is documented.

排除标准

  • Patients with persistent oligoarthritis subtype or systemic JIA having systemic features (within 1 year prior to inclusion) are excluded. In addition, patients may not have received treatment with steroids in the month before remission is first documented or treatment with intraarticular joint injections etc. in the 6 months before remission is first documented. Patient with a history of uveitis or macrophage activation syndrome are excluded. Patients may also not be included if withdrawal of any biological drug has ever been unsuccessful in the past.

研究者

发起方
Interdisciplinary Center For Clinical Research Muenster (Interdisziplinäres Zentrum für Klinische Forschung) (Germany)

相似试验